Celiac disease (CD) is associated with increased mortality rate and adverse pregnancy outcome, but little is known about offspring mortality rate. In this nationwide retrospective cohort study, we identified persons whose biopsy-verified CD was diagnosed in Sweden in . We compared mortality rates in children born to mothers with and without CD (n = 16,121 vs. n = 61,782) and children born to fathers with and without CD (n = 9,289 vs. n = 32,984). Median age of offspring at end of follow-up was 28.7 (range, 16.7-39.7) years. We also examined mortality rates in children born to mothers with undiagnosed CD (later CD diagnosis; n = 12,919) and diagnosed CD (n = 3,202) to determine if intrauterine exposures associated with CD could affect offspring mortality rate. We estimated hazard ratios for death by using Cox regression. Death rates were independent of maternal CD (60 deaths per 100,000 person-years in children of mothers with CD, vs. 54 in controls) and paternal CD (53 deaths per 100,000 person-years in children of fathers with CD, vs. 53 in controls). Corresponding adjusted hazard ratios were 1.09 (95% confidence interval: 0.95, 1.26) for maternal CD and 1.02 (95% confidence interval: 0.85, 1.23) for paternal CD. Death rates were similar in children born to mothers with undiagnosed CD and in children whose mothers had diagnosed CD during pregnancy. Parental CD does not seem to influence mortality rate in offspring, which suggests that neither genetic influences of CD nor intrauterine conditions have adverse effects on offspring mortality rate.
Celiac disease (CD), an immune-mediated disorder triggered by the intake of gluten in genetically susceptible persons, occurs practically worldwide, and the prevalence is 1%-2% in Western countries (1, 2) . Persons with CD are at increased risk of death (3, 4) and several comorbid conditions, including type 1 diabetes mellitus and lymphoproliferative disease (5) .
We (6, 7) and others (8) (9) (10) (11) (12) (13) have shown that maternal CD is associated with increased risks of adverse pregnancy outcomes. However, the excess risk might be limited to undiagnosed CD (7, 13) , in which inflammation and maternal malnutrition are particularly likely to occur (7, 14, 15) . Several studies have shown that prenatal exposure to maternal infections (e.g., maternal Ureaplasma urealyticum and Mycoplasma hominis) and malnutrition is related to increased risk of death in the offspring (16) , potentially explained by an increased risk of spontaneous preterm birth (17) , which might be linked to increased risk of death in young adulthood (18) . Malnutrition during pregnancy also increases the risk of intrauterine growth restriction. Although controversial, the fetal programming hypothesis (19) suggests that fetal nutrition will affect the child's health later in life-for example, the risk of cardiovascular disease. Specific micronutrient deficiencies, such as folic acid deficiency (often seen in CD (20, 21) ), have also been linked to congenital malformations (22) and could thereby increase risks of morbidity and mortality.
Infants born to mothers with undiagnosed CD are more often born preterm (7) . Preterm birth is the main cause of infant death (death during the first year of life) and recently was shown to increase the risk of childhood death (18) .
Data on paternal CD and risks of pregnancy outcomes are scarce (6, 23) , but the largest study to date did not show an association (23) . Still, both men and women with CD are at increased risk of death (4) . If genetic factors contribute to this excess mortality risk, children born to fathers with CD also might be at increased risk of death. The aim of the present study was therefore to examine mortality risks in offspring (infants and children) of women and men with CD.
MATERIALS AND METHODS
We linked nationwide data on CD from biopsy reports to the Multi-generation Register (24), the Total Population Register (25) , the Swedish Cause of Death Register (26), the Medical Birth Register (27) , and the Patient Register (28) . We then estimated mortality risk in infants according to the CD status of their mothers and fathers. Table 1 , available at http://aje.oxfordjournals.org/). Positive CD serology was not a prerequisite for a diagnosis of CD, but a validation of randomly selected persons with CD showed that 88% had positive CD serology at the time of biopsy (30) . Additional details on the data collection process have been published elsewhere (30) . The present study was based on the same population sample (n = 29,096) described in our earlier paper on mortality rate in CD (4). Of 18,005 women with CD, we selected those giving birth to a live singleton infant between 1961 and 2009. Likewise, of the 11,091 men with CD, we selected those with a live singleton infant between 1961 and 2009 and retrieved information about maternal and obstetric factors from the Medical Birth Register.
Controls were sampled from all Swedish residents who had no prior duodenal or jejunal biopsy. For each mother and father with CD, the government agency Statistics Sweden identified up to 5 controls matched for age, sex, calendar year of birth, and county of residence. Among potential controls, we excluded those with a duodenal or jejunal biopsy during follow-up, those who died before the hypothetical biopsy date (matching date in controls), and those whose index case with CD had been excluded for any reason.
We then restricted our study to births to parents aged 15-45 years for whom data on educational level were available, because parental educational level can influence child health (0.4% of mothers and 0.6% of fathers had no data on educational level). Parents were linked to their children through the Swedish Multi-generation Register (24) . This registry contains data on persons born since 1932 and alive on January 1, 1961.
Outcome measure
Mortality data were obtained from the Swedish Cause of Death Register (26) . This registry has published annual reports throughout the 20th and 21st centuries. Our main outcome was overall death, with deaths occurring on the day of birth excluded to rule out the possibility that miscoded stillbirths were included. In a subanalysis, we specifically considered death from accidents (accidents: International Classification of Diseases, Eighth Revision codes 807-846, 869-929, 940-946, 960-978; Ninth Revision codes E800-E869, E880-E928; and Tenth Revision code V00-X5999) as a competing event for all other causes of death. Follow-up ended at death, emigration, or end of follow-up (December 31, 2010).
Exposure
Parental CD was our exposure. For fathers, we did not distinguish between undiagnosed or diagnosed CD at time of conception (birth date minus 280 days). For mothers, we examined offspring deaths in both undiagnosed and diagnosed CD because we assumed that treatment with a glutenfree diet (starting at diagnosis) might influence the intrauterine environment of the fetus (7).
Covariates
Starting in 1973, we obtained data from the Medical Birth Register (27, 31) on maternal smoking (available since 1982: 0, 1-9, and ≥10 cigarettes per day) and maternal civil status (also available since 1982: living with the father of the child: yes vs. no). Data on maternal country of birth (Nordic vs. other country) were obtained from the Total Population Register (25) . Data on parental age (6 categories in 5-year increments) at conception, parity (0, 1-2, and ≥3 pregnancies), and sex of the child were obtained from the Multigeneration Register (24) . We used the national Patient Register (28) and relevant codes from the International Classification of Diseases to identify mothers with type 1 diabetes mellitus, autoimmune thyroid disease, and rheumatoid arthritis (see the Web Appendix).
Data on maternal educational level were obtained from the national Education Register. Educational level was classified into 4 categories: ≤9 years of primary and secondary school, 2 years of high school (usually programs for manual, clerical, or assistance work), 3 years of high school (theoretical programs), and college/university studies.
Statistics
Two main analyses were conducted: First, we compared death rates in children of parents with or without CD (both mothers and fathers). If mortality rate were increased in children of both fathers and mothers with CD, this would suggest that genetic factors increased the risk of death. Second, we compared death rates in children of mothers with undiagnosed and diagnosed CD with those in children of mothers without CD. If mortality rate were increased only in children of mothers with CD, this would suggest that CD-related intrauterine factors influenced risk of death. Previous research has shown that undiagnosed CD, but not diagnosed CD, affects important pregnancy outcomes, such as birth weight and gestational age (7) . For consistency, we also examined mortality rate in offspring of fathers with undiagnosed and diagnosed CD. If genetic factors would affect infant risk of death, an excess mortality rate would appear in offspring born both before and after paternal CD diagnosis.
Although the matching was lost, because the number of births differed between mothers with and without diagnosed CD (and fathers, respectively), we conducted the analyses separately for each matching group to reduce heterogeneity in the infant birth year distributions between mothers with and without diagnosed CD. We used Cox regression (32) to estimate hazard ratios for overall death after testing the proportionality assumption by scaled Schoenfeld residuals, with time since infant birth as the principal time scale.
After identifying deaths from accidents, we modeled the probability of occurrence of nonaccidental deaths by using a proportional subdistribution hazards model (Fine and Gray Table continues 1350 Zugna et al.
model) (33, 34) . This model estimates the hazard corresponding to the cause-specific cumulative incidence functionthat is, the probability of the event of interest occurring before other competing events. However, because of the small number of deaths from accidents, this estimate is similar to that obtained by the Cox model (for simplicity, we will refer to it as hazard ratio).
In all analyses, we adjusted for maternal or paternal age, country of birth, educational level, and total number of children and for infant's year of birth and sex. We also considered infant's calendar year of birth and the appearance of maternal diabetes mellitus, thyroid disease, and rheumatoid arthritis as time-dependent variables in the models, but inclusion of these factors did not modify the exposure effect on mortality risk. We did not include variables such as birth weight, gestational age, caesarean delivery, and subsequent appearance of CD in the child because these variables could be mediators in the pathway between parental CD and offspring death (7) .
Potential effect modifications were evaluated by including interaction terms between the exposure and all other variables in the models and testing for their statistical significance by likelihood ratio tests. Standard errors for intra-group correlation were adjusted by clustering the multiple births observed for each woman. As sensitivity analyses in comparing women with CD (undiagnosed and diagnosed) with women without CD, we also conducted models by restricting the analyses to 5 years of follow-up and by adjusting for smoking habits and civil status.
Finally, exposure misclassification could be possible because the final biopsy report was dated February 2008, whereas the follow-up extended through December 2010. In fact, in mothers assessed as unexposed, CD could have been diagnosed in this interval of time. However, estimates of mortality risk were not changed by interruption of the follow-up in 2008 (data not shown).
Statistics were calculated in Stata, version 11.1 (StataCorp LP, College Station, Texas) and R, version 2.11.1 (The R Foundation for Statistical Computing, Vienna, Austria).
Ethics
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RESULTS

Background data
This study was based on 7,784 women with CD, 29,066 women without CD, 4,426 men with CD, and 15,613 men without CD. Some mothers and fathers contributed more than 1 child to the study. Hence, the numbers of children in this study were as follows: to mothers with CD, 16,121; to mothers without CD, 61,782; to fathers with CD, 9,289; and to fathers without CD, 32,984. Descriptive characteristics are reported in Table 1 . Both mothers and fathers with CD were more often born in the Nordic countries. Some 1,255 mothers (16.1%) with CD and 688 fathers (15.5%) also had an inpatient diagnosis of CD.
Mortality rate in children born to parents with CD
Death rates were independent of maternal CD (60 deaths per 100,000 person-years in children of mothers with CD, vs. 54 in controls) or paternal CD (53 deaths per 100,000 person-years in children of fathers with CD, vs. 53 in controls) (see also Tables 2 and 3 ). Estimates did not change after exclusion of accidental deaths (adjusted hazard ratio (HR) = 1.09, 95% confidence interval (CI): 0.93, 1.26 in mothers; adjusted HR = 1.04, 95% CI: 0.85, 1.28 in fathers).
Mortality rate in children of mothers with diagnosed and undiagnosed CD
These analyses were based on 12,919 children born to mothers with undiagnosed CD and 3,202 children born to mothers with diagnosed CD, vs. 53,186 and 12,957 children born to matched unexposed women, respectively (Web Table 2 ). Descriptive data on these children are reported in Web Table 3 . Because women with diagnosed CD gave birth after their biopsy, most of these births took place by the end of the study period, and consequently, these children had shorter follow-up periods.
Compared with children of mothers without CD, neither children of mothers with undiagnosed CD nor children of mothers with diagnosed CD had increased mortality risks (Table 4) . Adjustment for potential confounders did not change the risk estimate in children of mothers with undiagnosed CD, whereas the mortality risk and CI increased Abbreviations: CD, celiac disease; CI, confidence interval; HR, hazard ratio. a Analyses adjusted for maternal/paternal age, maternal/paternal country of birth, maternal/paternal educational level, maternal/paternal total number of children, and infant's year of birth. We also considered calendar year of birth and the appearance of maternal diabetes, thyroid disease, and rheumatoid arthritis as time-dependent variables in the models.
slightly, although still not significantly, in children of mothers with diagnosed CD (Table 4) .
The risk of death did not differ between male and female children born to women with undiagnosed CD (interaction term: P = 0.10). In contrast, all 13 deaths in children of mothers with diagnosed CD occurred in males. For 10 of these 13 children, we were able to identify the cause of death (see the Web Appendix). Undiagnosed and diagnosed CD in the mother was not associated with increased risk of nonaccidental death (undiagnosed CD: HR = 1.07, 95% CI: 0.92, 1.26; diagnosed CD: HR = 1.30, 95% CI: 0.65, 2.58).
When the analyses were restricted to 5 years of follow-up, estimates of risk of death in children born to women with undiagnosed CD increased slightly (undiagnosed CD: HR = 1.23; 95% CI: 0.99, 1.54), whereas they did not change in children born to women with diagnosed CD (diagnosed CD: HR = 1.22: 95% CI: 0.60, 2.48). After adjustment for prenatal smoking exposure and civil status in a subset of mothers (children born from 1982 onward), there was still no increased risk of offspring death (undiagnosed CD: HR = 1.27; 95% CI: 0.80, 2.00; diagnosed CD: HR = 1.12: 95% CI: 0.54, 2.32).
In a post hoc analysis, we also restricted our analyses to the first year of follow-up. The hazard ratios for offspring death were then 0.74 (95% CI: 0.30, 1.85) among mothers with undiagnosed CD and 1.32 (95% CI: 1.03, 1.67) among mothers with diagnosed CD.
DISCUSSION
In this nationwide cohort study, we found no association of either maternal or paternal CD with risk of death in offspring. These findings are important because previous studies have indicated a detrimental effect of maternal undiagnosed CD on pregnancy outcome (7, 13) . Our data also suggest that the excess mortality rate seen in patients with CD (3, 4, 35) is not translated into an excess mortality rate in the children born to these patients. With the exception of some studies on stillbirth (9, 12, 36, 37) , often showing a nonsignificantly increased risk of stillbirth in women with CD (9, 12) , the present study is, to our knowledge, the first study on mortality rate in liveborn children of parents with CD.
Although research has shown that children born to mothers with undiagnosed CD have a lower birth weight and a shorter gestational age at birth (7, 13) , these children were at no increased risk of death. Moreover, similar results were obtained after exclusion of deaths from accidents.
The lack of excess mortality rate in offspring suggests that malnutrition and inflammation during pregnancy in women with undiagnosed CD in a Swedish setting do not confer an obvious increased risk of death in their offspring. However, we cannot rule out that in countries where antenatal and perinatal health care is lacking, prenatal exposure from CD could influence offspring mortality rate.
Although the risk of death in children born to mothers with CD differed by sex, this was mainly due to a lowerthan-expected risk of death in females. We cannot dismiss the possibility that this was a chance finding, and it should be emphasized that in neither male nor female offspring was the mortality risk statistically significantly different from that of control offspring. We also examined mortality rate in the offspring of fathers with CD, hypothesizing that if genetic factors were responsible for the increased mortality rate seen in CD (4), we would find an increased mortality rate in children of both women and men with CD. We found no mortality rate increase in children of fathers with CD. Nevertheless, it should be noted that death is only the most severe endpoint of prenatal exposure and that other deleterious effects on growth and development might be present in offspring to parents with CD.
Strengths and limitations
The main strengths of the present study are its statistical power, its ability to distinguish between undiagnosed and diagnosed CD, and its power to discriminate between children of mothers and fathers with CD. Making the distinction between mothers and fathers with CD (and between undiagnosed and diagnosed CD in mothers) is important because it could provide important insight into the origin of an increased mortality rate in the offspring of parents with CD. Further strengths include the nationwide population-based design with a validated CD diagnosis. This study ascertained CD through a biopsy register. This approach had the inherent advantage of supplying us with exact information on date of diagnosis as well as the possible starting point of a gluten-free diet. Small-intestinal biopsies have a high sensitivity for diagnosed CD. More than 95% of all Swedish pediatricians and gastroenterologists perform biopsies on their patients with suspected CD before diagnosis (30) . We examined 114 medical records from patients with VA, and Abbreviations: CD, celiac disease; CI, confidence interval; HR, hazard ratio. a Analyses adjusted for maternal/paternal age, maternal/paternal country of birth, maternal/paternal educational level, maternal/paternal total number of children, and infant's year of birth. We also considered calendar year of birth and the appearance of maternal diabetes, thyroid disease, and rheumatoid arthritis as time-dependent variables in the models.
Mortality Rate in Offspring of Parents With Celiac Disease 1353 from this examination we were able to calculate a positive predictive value of 95% for CD (i.e., in 108 cases, the VA represented CD) (30) . When we manually reviewed more than 1,500 biopsy reports, diagnoses other than CD were very rare. (Inflammatory bowel disease was the most common non-CD disorder in patients with VA but only accounted for 0.3% of all VA.) (30) . Biopsy reports were based on a median of 3 tissue specimens and should detect about 95% of patients with CD (38) . Furthermore, the national Cause of Death Register has high validity. In 1995, the National Board of Health and Welfare received death certificates for 99.7% of all deaths.
We lacked individual data on dietary adherence. In a random sample of persons with CD, 17% had indications of low dietary adherence according to patient medical records (30) . However, because offspring mortality rate was not increased in children born to mothers with undiagnosed CD (none of these mothers should have been on a gluten-free diet), we do not think that the absence of a gluten-free diet influences offspring mortality rate. The age when a glutenfree diet is started (39) and duration of gluten-free diet (40) have otherwise been suggested to influence future risk of comorbid conditions. Because of a short follow-up of children born to CD-diagnosed mothers and fathers and hence because of the rarity of our outcome measure, we had limited statistical power to detect an increased risk of death in children of mothers and fathers with diagnosed CD. The mortality risk in children of mothers with diagnosed CD was otherwise almost identical to that found in our previous study on overall mortality rate in patients who themselves had CD (4). However, given that we saw no excess mortality rate in children of mothers with undiagnosed CD, we believe our null findings reflect a neutral risk in children of mothers with diagnosed CD. Moreover, we did not have enough power to analyze different causes of death separately. Thus, our study cannot preclude effects on specific causes of deaths not frequent enough to emerge in analyses on overall mortality rate.
Because we were interested in the estimation of the total effect of CD on offspring mortality rate (also through its effect on variables related to infant births), we did not adjust for potential mediators (e.g., birth weight, gestational age). In this framework, an appropriate mediation analysis is required to estimate the direct and indirect effects (through mediators) of CD diagnosis on offspring mortality rate. Indeed, simple adjustment for mediators could introduce bias in the effects estimates. Given that children of women with undiagnosed CD are more often preterm and small for gestational age, adjustment for these variables would have resulted in an even lower hazard ratio for offspring mortality rate in women with undiagnosed CD (7) . Research has shown that children born to mothers with diagnosed CD during pregnancy and children born to fathers with CD are not at increased risk of being born preterm or small for gestational age. It is therefore unlikely that adjustment for birth weight and gestational age in women with diagnosed CD (7) or in men with either undiagnosed or diagnosed CD (23) would affect mortality risk estimates.
In conclusion, we found no evidence of an association between parental CD and offspring death.
